Martin Fan
Stock Analyst at Wedbush
(4.96)
# 166
Out of 5,182 analysts
28
Total ratings
70.83%
Success rate
90.93%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Martin Fan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NKTR Nektar Therapeutics | Maintains: Neutral | $70 → $95 | $86.74 | +9.53% | 2 | Apr 21, 2026 | |
| ORKA Oruka Therapeutics | Maintains: Outperform | $45 → $85 | $76.39 | +11.27% | 4 | Apr 15, 2026 | |
| SANA Sana Biotechnology | Maintains: Outperform | $6 → $7 | $3.26 | +114.72% | 3 | Apr 14, 2026 | |
| VOR Vor Biopharma | Maintains: Neutral | $9 → $15 | $14.12 | +6.23% | 2 | Mar 31, 2026 | |
| ACRS Aclaris Therapeutics | Reiterates: Outperform | $8 | $4.41 | +81.41% | 2 | Mar 31, 2026 | |
| ANAB AnaptysBio | Maintains: Outperform | $60 → $75 | $66.59 | +12.63% | 6 | Mar 12, 2026 | |
| RNAC Cartesian Therapeutics | Reiterates: Outperform | $38 | $7.07 | +437.48% | 2 | Mar 10, 2026 | |
| ZURA Zura Bio | Initiates: Outperform | $15 | $5.41 | +177.26% | 1 | Feb 9, 2026 | |
| ZBIO Zenas BioPharma | Reiterates: Outperform | $45 | $18.59 | +142.07% | 3 | Dec 22, 2025 | |
| IMA ImageneBio | Assumes: Underperform | $2 | $5.83 | -65.69% | 1 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $23 | $10.75 | +113.95% | 2 | Oct 17, 2025 |
Nektar Therapeutics
Apr 21, 2026
Maintains: Neutral
Price Target: $70 → $95
Current: $86.74
Upside: +9.53%
Oruka Therapeutics
Apr 15, 2026
Maintains: Outperform
Price Target: $45 → $85
Current: $76.39
Upside: +11.27%
Sana Biotechnology
Apr 14, 2026
Maintains: Outperform
Price Target: $6 → $7
Current: $3.26
Upside: +114.72%
Vor Biopharma
Mar 31, 2026
Maintains: Neutral
Price Target: $9 → $15
Current: $14.12
Upside: +6.23%
Aclaris Therapeutics
Mar 31, 2026
Reiterates: Outperform
Price Target: $8
Current: $4.41
Upside: +81.41%
AnaptysBio
Mar 12, 2026
Maintains: Outperform
Price Target: $60 → $75
Current: $66.59
Upside: +12.63%
Cartesian Therapeutics
Mar 10, 2026
Reiterates: Outperform
Price Target: $38
Current: $7.07
Upside: +437.48%
Zura Bio
Feb 9, 2026
Initiates: Outperform
Price Target: $15
Current: $5.41
Upside: +177.26%
Zenas BioPharma
Dec 22, 2025
Reiterates: Outperform
Price Target: $45
Current: $18.59
Upside: +142.07%
ImageneBio
Nov 25, 2025
Assumes: Underperform
Price Target: $2
Current: $5.83
Upside: -65.69%
Oct 17, 2025
Maintains: Outperform
Price Target: $18 → $23
Current: $10.75
Upside: +113.95%